In 2023, the percentage of men aged 50-74 screened for colorectal cancer in France stood significantly below future forecasts. Observing the forecast data, there is a steady, albeit modest, year-on-year growth, starting from 31.2% in 2024 and gradually increasing by around 0.1% to 0.2% each subsequent year to reach 31.9% in 2028. The consistent year-on-year rise suggests a slight upward trend, pointing towards increased colorectal cancer screening adoption among the target demographic. The compound annual growth rate (CAGR) over this period indicates a stable, incremental increase in screening rates.
Future trends to watch for include potential policy changes impacting healthcare accessibility, technological advancements in screening methods, and public awareness campaigns that could further influence participation rates. Monitoring these factors will be critical as they can accelerate the current growth trajectory in colorectal cancer screening prevalence.
